From: Development of a perioperative medicine research agenda: a cross sectional survey
Research issues | Total | 95% (CI) | High** volume | Low volume | Academic | Non-academic |
---|---|---|---|---|---|---|
The value of tight control of diabetes mellitus postoperatively. | 7.2 (1) | 6.8–7.6 | 7.2 (1) | 7.1 (2) | 7.1 (3) | 7.2 (1) |
Starting aspirin on patients at increased risk for postoperative cardiac complications. | 7.1 (2) | 6.7–7.5 | 7.2 (2) | 7.0 (4) | 7.1 (4) | 7.1 (2) |
Safety and efficacy of continuing aspirin preoperatively for those already taking aspirin. | 7.0 (3) | 6.6–7.4 | 7.0 (5) | 7.1 (1) | 7.1 (5) | 7.0 (3) |
Optimal management of perioperative anticoagulation for patients with prosthetic valves. | 7.0 (4) | 6.5–7.4 | 6.9 (6) | 7.1 (3) | 7.0 (6) | 7.0 (4) |
The value of starting angiotensin converting enzyme inhibitors for those at increased risk of postoperative cardiac complications. | 6.9 (5) | 6.5–7.3 | 7.2 (3) | 6.7 (9) | 7.0 (7) | 6.9 (7) |
Determining the diagnostic yield of routine postoperative cardiac surveillance. | 6.8 (6) | 6.4–7.2 | 7.1 (4) | 6.6 (13) | 6.5 (12) | 6.9 (6) |
Developing interventions to minimize postoperative delirium. | 6.8 (7) | 6.4–7.2 | 6.5 (9) | 7.0 (6) | 6.4 (14) | 6.9 (5) |
The value of starting beta-blockers for patients at increased risk of postoperative cardiac complications. | 6.7 (8) | 6.2–7.2 | 6.4 (11) | 7.0 (5) | 7.2 (1) | 6.6 (10) |
Optimal management of perioperative anticoagulation for patients with atrial fibrillation. | 6.6 (9) | 6.2–7.1 | 6.3 (12) | 6.9 (7) | 6.6 (11) | 6.7 (9) |
Developing a risk stratification index for predicting postoperative pulmonary complications | 6.6 (10) | 6.2–7.1 | 6.6 (8) | 6.7 (10) | 6.5 (13) | 6.7 (8) |